摘要
目的基于疼痛数字评定量表(NRS)制定蛛网膜下腔出血术后患者的疼痛管理措施,并探讨其应用成效。方法采取便利抽样法,选取70例蛛网膜下腔出血术后患者,按照入院时间顺序分为2组,即2020年3—6月收治的患者为对照组(35例),2020年7—10月收治的患者为观察组(35例)。对照组实施常规疼痛护理,观察组联合多学科团队,基于NRS评分实施分级疼痛管理。比较2组患者干预后NRS评分、一般自我效能感量表(GSES)评分及并发症发生率。结果干预1 d时,2组患者NRS评分比较差异无统计学意义(P>0.05);干预3、5 d时观察组NRS评分低于对照组,干预15 d时GSES评分高于对照组,差异均有统计学意义(P<0.001);2组并发症发生率比较,差异无统计学意义(P>0.05)。结论多学科团队联合NRS评分实施的疼痛管理有利于改善SAH患者术后疼痛结局,提高患者自我效能感。
Objective To develop a pain management program for patients with subarachnoid hemorrhage(SAH)after surgery based on the Numeric Rating Scale(NRS),and to explore its application effect.Methods Seventy patients who underwent SAH surgery were selected by convenience sampling method.According to the order of admission,these patients were divided into two groups:control group(35 cases,admission from March to June 2020)and observation group(35 cases,admission from July to October 2020).The control group received routine pain care,while the observation group was given graded pain management based on multidisciplinary team combined with NRS score.After intervention,NRS score,General Self-Efficacy Scale(GSES)score and incidence of complications were compared between the two groups.Results There was no significant difference in NRS score between the two groups after intervention for 1 day(P>0.05).After intervention for 3 and 5 days,NRS score in the observation group was lower than that in the control group(P<0.001).Furthermore,GSES score in the observation group was higher than that in the control group after intervention for 15 days(P<0.001).No significant difference in the incidence of complications was found between the two groups(P>0.05).Conclusion Pain management based on multidisciplinary team combined with NRS score can improve postoperative pain outcome and perceived self-efficacy in SAH patients.
作者
李星茹
张超
LI Xing-ru;ZHANG Chao(School of Nursing,Nanchang University,Nanchang 330006,China;Department of Nursing,the Second Affiliated Hospital,Nanchang University,Nanchang 330006,China)
出处
《南昌大学学报(医学版)》
2022年第2期65-68,共4页
Journal of Nanchang University:Medical Sciences
基金
江西省卫健委一般科技计划(202130456)
江西省研究生专项基金项目(YC2020-S138)。